Search research articles
Contact Us
Filters
Showing results (11-20 of 85) with videos related to
Page
of 9
Sort By:
Stroke
|
March 17, 2009
Immune response in human cerebral cavernous malformations
Changbin Shi, Robert Shenkar, Hongyan Du, et al.
Neurosurgery
|
January 27, 2005
Variations in structural protein expression and endothelial cell proliferation in relation to clinical manifestations of cerebral cavernous malformations
Robert Shenkar, Hemant Sarin, Nabil A Awadallah, et al.
Neurosurgery
|
July 4, 2009
Cerebral cavernous malformations: somatic mutations in vascular endothelial cells
Judith Gault, Issam A Awad, Peter Recksiek, et al.
Neurosurgery
|
November 5, 2008
Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions
Robert Shenkar, Palamadai N Venkatasubramanian, Jin-cheng Zhao, et al.
Journal of Neuroimmunology
|
May 28, 2014
Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations
Changbin Shi, Robert Shenkar, Andrew Kinloch, et al.
Stroke
|
October 29, 2011
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease
David A McDonald, Changbin Shi, Robert Shenkar, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
September 14, 2021
COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation
Abdallah Shkoukani, Abhinav Srinath, Agnieszka Stadnik, et al.
Neurosurgery
|
November 5, 2008
Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models
Robert Shenkar, Palamadai N Venkatasubramanian, Alice M Wyrwicz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 9, 2022
β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations
Sara McCurdy, Jenny Lin, Robert Shenkar, et al.
ACS Pharmacology & Translational Science
|
May 20, 2022
Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans
Matthew J Hagan, Robert Shenkar, Abhinav Srinath, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 85) with videos related to
Sort By:
Page
of 9
Stroke
|
March 17, 2009
Immune response in human cerebral cavernous malformations
Changbin Shi, Robert Shenkar, Hongyan Du, et al.
Neurosurgery
|
January 27, 2005
Variations in structural protein expression and endothelial cell proliferation in relation to clinical manifestations of cerebral cavernous malformations
Robert Shenkar, Hemant Sarin, Nabil A Awadallah, et al.
Neurosurgery
|
July 4, 2009
Cerebral cavernous malformations: somatic mutations in vascular endothelial cells
Judith Gault, Issam A Awad, Peter Recksiek, et al.
Neurosurgery
|
November 5, 2008
Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions
Robert Shenkar, Palamadai N Venkatasubramanian, Jin-cheng Zhao, et al.
Journal of Neuroimmunology
|
May 28, 2014
Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations
Changbin Shi, Robert Shenkar, Andrew Kinloch, et al.
Stroke
|
October 29, 2011
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease
David A McDonald, Changbin Shi, Robert Shenkar, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
September 14, 2021
COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation
Abdallah Shkoukani, Abhinav Srinath, Agnieszka Stadnik, et al.
Neurosurgery
|
November 5, 2008
Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models
Robert Shenkar, Palamadai N Venkatasubramanian, Alice M Wyrwicz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 9, 2022
β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations
Sara McCurdy, Jenny Lin, Robert Shenkar, et al.
ACS Pharmacology & Translational Science
|
May 20, 2022
Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans
Matthew J Hagan, Robert Shenkar, Abhinav Srinath, et al.
Page
of 9